Table 2. T2D susceptible alleles and genotype frequencies for the ERF participants.

Locus	Chr	SNPs	Position (bp)	Alleles	N	Allele Freq. (n)	Genotype Frequencies (n)	Phw	Freq. Ref.
				A1/A2		A1	A2	A1A1	A1A2	A2A2
IGF2BP2	3	rs4402960	186994389	T/G	2891	28.8	71.2	8.8	40.1	51.1	0.238	0.29–0.30
						(833)	(2058)	(253)	(1159)	(1479)
CDKN2B	9	rs10811661	22124094	T/C	2888	86.6	13.4	75.1	23	1.9	0.748	0.83–0.85
						(2501)	(387)	(2168)	666	54
CDKAL1	6	rs7754840	20769229	C/G	2871	32.7	67.3	11.4	43.3	45.3	0.127	0.31–0.36
						(993)	(2115)	(326)	(1229)	(1316)
PPARG	3	rs1801282	12368125	C/G	2955	90.1	9.9	81.3	17.7	1	0.757	0.82–0.86
						(2662)	(293)	(2402)	(523)	(30)
SLC30A8	8	rs13266634	118253964	C/T	2934	69.2	30.8	47.4	43.6	9	0.260	0.61–0.75
						(2030)	(904)	(1391)	(1278)	(265)
HHEX	10	rs1111875	94452862	C/T	2940	59.2	40.8	34.9	48.4	16.7	0.939	0.52–0.64
						(1740)	(1200)	(1028)	(1423)	(489)
KCNJ11	11	rs5219	17366148	T/C	2935	33.6	66.4	11.4	44.4	44.2	0.804	0.46–0.47
						(986)	(1949)	(335)	(1304)	(1296)
TCF7L2	10	rs7903146	114748339	T/C	2916	28.5	71.5	7.8	41.3	50.9	0.467	0.18–0.26
						(831)	(2084)	(228)	(1204)	(1482)
FTO	16	rs8050136	52373776	A/C	2942	43.1	56.9	17.2	51.8	31.0	0.011	0.38
						(1268)	(1674)	(505)	(1524)	(913)

Chr. = Chromosome, Risk allele for type 2 diabetes underlined. Phw = p value for hardy-weinberg. Freq. Ref. = reference frequency.